Active and arrested paramyxovirus fusion machinery visualized by cryo-electron to
通过冷冻电子可视化活跃和停滞的副粘病毒融合机制
基本信息
- 批准号:8540333
- 负责人:
- 金额:$ 22.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-07 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): New imaging strategy to address challenges in the field. The lethal and transmissible nature of the paramyxoviruses Hendra virus and Nipah virus (HeV, NiV) makes these pathogens of serious concern. These are also ideal models for developing an innovative new imaging platform at the interface between bioengineering and virology. Despite the relative abundance of crystal structure data for the paramyxovirus fusion machinery, the dynamic processes - starting with the binding of virus to the host cell and ending with infection -- are poorly understood. The interplay between the envelope viral glycoproteins that leads to activation of the fusion process has eluded rigorous analysis. Imaging the viral fusion nano-machinery will deepen our understanding of viral membrane fusion and will allow us to identify strategies for interfering with the process and arresting the infection cycle. We propose to capture, immobilize, and visualize activated intermediate states of the fusion process, exposing the conserved domains that are essential for viral entry. While the activated conformation is normally present only at the surface of live cells, we propose to use engineered liposomes to capture and immobilize transitional states. We will use receptor molecules, presented in a biomimetic fashion on the surface of the liposomes, to "trigger" the fusion protein and activate the conformational change in the viral fusion machinery. We will then use fusion inhibitory peptides to arrest the fusion machinery in its activated state, and thus immobilize the captured intermediates with the liposomes. These complexes will then be analyzed by cryo-electron tomography. Aim 1. Generate NiV fusion machinery intermediate states 1.1 Trapping intermediate states of the NiV fusion machinery. We will capture the NiV fusion machinery at intermediate stages of the fusion reaction, by first activating the fusion process using cellular receptor molecules presented on liposomes, and then trapping fusion intermediates with fusion-inhibitory peptides that block the conformational refolding of the fusion protein that is required for completing membrane fusion. 1.2 Functional and morphological studies of different states of the fusion process. Fluorescence spectroscopy and negative-stain transmission electron microscopy will be used to determine the stability of the captured complexes from sub aim 1.1. Aim 2. Determine how the receptor binding and fusion proteins interact during binding and fusion activation Electron cryo-tomography (ECT) imaging of NiV fusion machinery. Using ECT we will visualize the process and requirements for the NiV receptor binding protein (G) to trigger fusion (F) protein-mediated fusion and subsequent steps in F structural rearrangement.
描述(由申请人提供):应对现场挑战的新成像策略。 hendra病毒和尼帕病毒(HEV,NIV)的致命性和可传染性质使这些病原体引起了严重关注。这些也是在生物工程和病毒学之间开发创新的新成像平台的理想模型。尽管帕托及病毒融合机械的晶体结构数据相对丰富,但动态过程 - 从病毒与宿主细胞结合并以感染结束的动态过程 - 知识渊博。融合过程激活的包膜病毒糖蛋白之间的相互作用已避免了严格的分析。成像病毒融合纳米机械将加深我们对病毒膜融合的理解,并使我们能够确定干扰该过程并阻止感染周期的策略。我们建议捕获,固定和可视化融合过程的激活的中间状态,以暴露对病毒进入必不可少的保守域。尽管通常仅存在活性构象,但我们建议使用工程脂质体捕获和固定过渡状态。我们将使用脂质体表面以仿生方式呈现的受体分子来“触发”融合蛋白,并激活病毒融合机械的构象变化。然后,我们将使用融合抑制性肽将融合机器以其活化状态阻止,从而将捕获的中间体与脂质体固定。然后,这些复合物将通过冷冻电子层析成像进行分析。 AIM 1。生成NIV融合机械中间状态1.1 NIV融合机械的中间状态。我们将通过首先使用脂质体上呈现的细胞受体分子激活融合过程,然后将融合融合中间体与融合抑制性抑制性的肽一起捕获融合过程,从而捕获NIV融合机制,从而捕获融合过程。 1.2融合过程的不同状态的功能和形态学研究。荧光光谱和负染色的透射电子显微镜将用于确定Sub AIM 1.1捕获的配合物的稳定性。 AIM 2。确定在NIV融合机械的结合和融合激活电子冷冻术(ECT)成像过程中,受体结合和融合蛋白如何相互作用。使用ECT,我们将可视化NIV受体结合蛋白(G)的过程和要求,以触发融合(F)蛋白介导的融合以及F结构重排的后续步骤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Matteo Porotto的其他基金
Design of fusion inhibitors to block measles host-to-host infection
设计融合抑制剂来阻止麻疹宿主间感染
- 批准号:1075371110753711
- 财政年份:2023
- 资助金额:$ 22.1万$ 22.1万
- 项目类别:
Design of fusion inhibitors to block measles host-to-host infection
设计融合抑制剂来阻止麻疹宿主间感染
- 批准号:1045708110457081
- 财政年份:2021
- 资助金额:$ 22.1万$ 22.1万
- 项目类别:
Fusion inhibitors that block host-to-host transmission of SARS-CoV-2
阻止 SARS-CoV-2 宿主间传播的融合抑制剂
- 批准号:1045795910457959
- 财政年份:2021
- 资助金额:$ 22.1万$ 22.1万
- 项目类别:
Fusion inhibitors that block host-to-host transmission of SARS-CoV-2
阻止 SARS-CoV-2 宿主间传播的融合抑制剂
- 批准号:1066897310668973
- 财政年份:2021
- 资助金额:$ 22.1万$ 22.1万
- 项目类别:
Fusion inhibitors that block host-to-host transmission of SARS-CoV-2
阻止 SARS-CoV-2 宿主间传播的融合抑制剂
- 批准号:1023760010237600
- 财政年份:2021
- 资助金额:$ 22.1万$ 22.1万
- 项目类别:
Small molecules to block measles spreading in the central nervous system
小分子阻止麻疹在中枢神经系统中传播
- 批准号:99862099986209
- 财政年份:2019
- 资助金额:$ 22.1万$ 22.1万
- 项目类别:
Development of therapeutic fusion inhibitor peptides for Measles encephalitis
开发治疗麻疹脑炎的融合抑制肽
- 批准号:1041490910414909
- 财政年份:2018
- 资助金额:$ 22.1万$ 22.1万
- 项目类别:
Development of therapeutic fusion inhibitor peptides for Measles encephalitis
开发治疗麻疹脑炎的融合抑制肽
- 批准号:1017812610178126
- 财政年份:2018
- 资助金额:$ 22.1万$ 22.1万
- 项目类别:
Development of therapeutic fusion inhibitor peptides for Measles encephalitis
开发治疗麻疹脑炎的融合抑制肽
- 批准号:99731019973101
- 财政年份:2018
- 资助金额:$ 22.1万$ 22.1万
- 项目类别:
Self-assembling nanoparticles for intranasal delivery of influenza fusion inhibitors
用于鼻内递送流感融合抑制剂的自组装纳米颗粒
- 批准号:94416949441694
- 财政年份:2016
- 资助金额:$ 22.1万$ 22.1万
- 项目类别:
相似国自然基金
“共享建筑学”的时空要素及表达体系研究
- 批准号:
- 批准年份:2019
- 资助金额:63 万元
- 项目类别:面上项目
基于城市空间日常效率的普通建筑更新设计策略研究
- 批准号:51778419
- 批准年份:2017
- 资助金额:61.0 万元
- 项目类别:面上项目
宜居环境的整体建筑学研究
- 批准号:51278108
- 批准年份:2012
- 资助金额:68.0 万元
- 项目类别:面上项目
The formation and evolution of planetary systems in dense star clusters
- 批准号:11043007
- 批准年份:2010
- 资助金额:10.0 万元
- 项目类别:专项基金项目
新型钒氧化物纳米组装结构在智能节能领域的应用
- 批准号:20801051
- 批准年份:2008
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Elucidating the Role of YAP and TAZ in the Aging Human Ovary
阐明 YAP 和 TAZ 在人类卵巢衰老中的作用
- 批准号:1072236810722368
- 财政年份:2023
- 资助金额:$ 22.1万$ 22.1万
- 项目类别:
Identifying epigenetic factors in control of epidermal stem cell longevity in the adult skin
识别控制成人皮肤表皮干细胞寿命的表观遗传因素
- 批准号:1072321210723212
- 财政年份:2023
- 资助金额:$ 22.1万$ 22.1万
- 项目类别:
Genomic and environmental drivers of HCC in Non-Hispanic Blacks: Nature and nurture
非西班牙裔黑人 HCC 的基因组和环境驱动因素:先天和后天
- 批准号:1085654610856546
- 财政年份:2023
- 资助金额:$ 22.1万$ 22.1万
- 项目类别:
Genetic Architecture of Aging-Related TDP-43 and Mixed Pathology Dementia
衰老相关 TDP-43 和混合病理痴呆的遗传结构
- 批准号:1065821510658215
- 财政年份:2023
- 资助金额:$ 22.1万$ 22.1万
- 项目类别:
Project 2: Impact of H1/H2 haplotypes on cellular disease-associated phenotypes driven by FTD-causing MAPT mutations
项目 2:H1/H2 单倍型对 FTD 引起的 MAPT 突变驱动的细胞疾病相关表型的影响
- 批准号:1083433610834336
- 财政年份:2023
- 资助金额:$ 22.1万$ 22.1万
- 项目类别: